2023

1. Endocannabinoid-Binding Receptors as Drug Targets

   Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

2. The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy

   Brain Sciences, Vol. 13, Núm. 9